EUVIMEDEUVIMED entdecken
Open Access

Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model

Taylor Morrisette iD, Kyle C Stamper, Katherine L Lev, Razieh Kebriaei, Dana J Holger, Jacinda C Abdul-Mutakabbir, Ashlan J Kunz Coyne, Michael J Rybak iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01317-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Taylor Morrisette und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University…. Hauptthemen laut MEDLINE: Rifampin, Staphylococcal Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Paratek Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilm-associated infections lead to substantial morbidity. Omadacycline (OMC) is a novel aminomethylcycline with potent in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis , but data surrounding its use in biofilm-associated infections are lacking.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinStaphylococcal InfectionsHumansStaphylococcus aureusAnti-Bacterial AgentsStaphylococcus epidermidisBiofilmsMicrobial Sensitivity TestsTetracyclines

Stichwörter der Autor:innen

biofilmomadacyclinerifampin

Substanzen

RifampinAnti-Bacterial AgentsomadacyclineTetracyclines

Autor:innen und Institutionen

  • Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
  • Division of Infectious Diseases, Department of Medicine, Wayne State University, Detroit, Michigan, USA.
  • Department of Pharmacy, Detroit Receiving Hospital, Detroit, Michigan, USA.

ORCID-Profile: Taylor Morrisette, Michael J Rybak

Förderung

  • NIAID NIH HHS
  • Paratek Pharmaceuticals

Zitieren

APA

Morrisette, T., Stamper, K. C., Lev, K. L., Kebriaei, R., Holger, D. J., Abdul-Mutakabbir, J. C., Kunz Coyne, A. J., & Rybak, M. J. (2023). Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01317-22

Vancouver

Morrisette T, Stamper KC, Lev KL, Kebriaei R, Holger DJ, Abdul-Mutakabbir JC, et al. Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01317-22

BibTeX
@article{Morrisette2023,
  author = {Morrisette, Taylor and Stamper, Kyle C and Lev, Katherine L and Kebriaei, Razieh and Holger, Dana J and Abdul-Mutakabbir, Jacinda C and Kunz Coyne, Ashlan J and Rybak, Michael J},
  title = {Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01317-22}
}
Kostenlos starten →